Clover Health Investments, Corp. /De
$2.32B- Market cap
- $2.23B
- Debt
- +$165.43M
- Cash
- −$78.30M
Capital structure 93% equity / 7% debt · EV / Revenue 1.20x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: CLOV stock price at discount vs OPK $4.26 current versus $7.58 implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at OPK's multiple
Implied fair value · at CLOV's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: CLOV FY 2025 (ended Dec 31, 2025) · OPK FY 2025 (ended Dec 31, 2025).
Trendline
Eight fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 93% equity / 7% debt · EV / Revenue 1.20x
Capital structure 64% equity / 36% debt · EV / Revenue 2.55x
CLOV carries the larger enterprise value at $2.32B against $1.55B; CLOV trades on the lower EV / Revenue multiple (1.20x vs 2.55x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
CLOVER HEALTH INVESTMENTS, CORP. /DE · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
OPKO Health, Inc. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.54x
0.54x
Net debt / EBITDA
Leverage against operating earnings
-1.02x
-3.03x
Cash and equivalents
Liquid reserves on the balance sheet
$78.30M
$364.41M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Alignment Healthcare, Inc.
CLOV vs ALHC
Oscar Health, Inc.
CLOV vs OSCR
MOLINA HEALTHCARE, INC.
CLOV vs MOH
CENTENE CORP
CLOV vs CNC
AMARIN CORP PLC\UK
CLOV vs AMRN
Sarepta Therapeutics, Inc.
CLOV vs SRPT
Amphastar Pharmaceuticals, Inc.
CLOV vs AMPH
SUPERNUS PHARMACEUTICALS, INC.
CLOV vs SUPN
Harmony Biosciences Holdings, Inc.
CLOV vs HRMY
$165.43M
$687.93M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.